Most Popular
Research Trend
Latest Discovery
COVID-19
Factors Contributing to the Age and Sex-Based Differences of the Novel Coronavirus - SARS-CoV-2/COVID-19
Jun 16, 2020
With the growing amount of coronavirus research accomplished by researchers globally, the value of the novel coronavirus (SARS-CoV-2) across many relevant research fields has been confirmed. According to big data analytics, the degree of coronavirus infection varies among different genders and different age groups. Read More >
Research Trend
Latest Discovery
COVID-19
Differences in COVID-19 Severity Across Patient Populations - Age and Gender
Jun 12, 2020
With the growing amount of coronavirus research accomplished by researchers globally, the value of the novel coronavirus (SARS-CoV-2) across many relevant research fields has been confirmed. According to big data analytics, the degree of coronavirus infection varies among different genders and different age groups. Read More >
Research Trend
MyD88 Signaling Pathway & IL-33 Induced Immune Response
Jun 08, 2020
The MYD88 gene encodes a cytosolic adapter protein, MyD88, which is involved in signaling for both the innate and adaptive immune response. The MyD88 adapter protein is essential for transducing signals in the interleukin-1 (IL-1) and toll-like receptor (TLR) pathways, which regulate activation of proinflammatory genes, and stimulating signaling molecules that activate interacting proteins called nuclear factor-kappa-B (NF-κB). Read More >
White Paper
Research Trend
Animal Models of Non-Alcoholic Fatty Liver Disease (NAFLD) and Steatohepatitis (NASH)
Jun 04, 2020
Non-alcoholic fatty liver disease (NAFLD), a hepatopathy syndrome affecting both adults and children, is characterized by a range of liver conditions affecting people who consume little to no alcohol, including simple fatty liver, steatohepatitis, fatty liver fibrosis, and cirrhosis. NAFLD can progress from simple fatty liver through nonalcoholic steatohepatitis (NASH) to liver fibrosis, and even lead to end-stage liver diseases, such as, liver cirrhosis, hepatocellular carcinoma (HCC), or liver failure. Read More >
Research Trend
Latest Discovery
The Latest Animal Models of Chronic Pancreatitis
May 28, 2020
While chronic pancreatitis (CP) is a relatively common disease, it remains difficult to treat. This is defined as a continuous or recurrent inflammatory pancreatic disease characterized by progressive and irreversible changes in pancreatic morphology. So far, scholars around the globe have done a lot of research on the diagnosis, treatment, and pathogenesis of the disease. Read More >
Newsletter
Breaking News
Cyagen Announces Support of Rare Genomic Institute’s BeHEARD Competition – Rare Disease Science Technology Grants Challenge
May 18, 2020
Cyagen Biosciences has committed to donate up to $83,250 of mouse model vector construction services as prizes for the Rare Genomic Institute’s BeHEARD (Helping Empower and Accelerate Research Discoveries) Challenge, which provides technology and financial grants for rare disease research. Read More >
Research Trend
White Paper
Latest Discovery
COVID-19
Understanding SARS-CoV-2: From the Origin to Current Research
May 13, 2020
The coronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become an ongoing global health emergency. Herein, we track the virus from its origin to current research efforts, with the aim of providing inspiration for further research and vaccine development. Read More >
Research Trend
COVID-19
Applications of Mouse Models for the Study of Coronavirus Diseases in Humans
May 07, 2020
The World Health Organization (WHO) announced the reclassification of the COVID-19 outbreak as a global pandemic on March 11, 2020. With the rapid spread of the disease across the globe, countries worldwide have joined the war against the SARS-CoV-2 virus. Read More >
Research Trend
Parkinson’s Disease (PD) – Researching Genetic Factors with Animal Models
Apr 29, 2020
Although most cases of Parkinson’s Disease (PD) are idiopathic, there is a small fraction of cases that have known genetic factors – presented in diagnoses of familial PD. Roughly 5% -15% of PD cases are due to a mutation occurring in one of several specific genes, commonly designated as PARK genes (due to their association with PD). Read More >
Newsletter
COVID-19
Cyagen to Remain Fully Operational Throughout COVID-19
Apr 27, 2020
Despite the effects of COVID-19 on global business, we are operating at 100% proficiency - providing uninterrupted production and technical support to ensure that your research continues. We will continue serving your model generation, cloning, and virus packaging needs with the same high quality and fast turnaround as before the outbreak. Read More >